Mode
Text Size
Log in / Sign up

High Neutrophil Extracellular Trap Levels Associated With Lower Functional Independence After Thrombectomy in Stroke

High Neutrophil Extracellular Trap Levels Associated With Lower Functional Independence After Thromb…
Photo by Logan Voss / Unsplash
Key Takeaway
Note the association between high NETs in thrombi and lower functional independence in this retrospective stroke cohort.

This single-center cohort study conducted at West China Hospital included 129 patients with acute ischemic stroke secondary to anterior circulation large vessel occlusion undergoing mechanical thrombectomy. The investigation focused on neutrophil extracellular traps (NETs) content in retrieved thrombi, comparing high-NETs and low-NETs groups over a 90-day follow-up period.

The primary outcome assessed functional independence defined as an mRS score of 0–2 at 90 days. Results indicated a significantly lower rate of functional independence in the high-NETs group, with rates of 35.2% versus 68.3% in the low-NETs group (p = 0.009). This suggests a negative association between elevated NETs content and favorable functional recovery following the procedure.

Secondary outcomes included admission blood glucose, prevalence of atrial fibrillation, and successful recanalization (mTICI 2b-3). Admission blood glucose was significantly higher in the high-NETs group (7.9 vs 6.7 mmol/L; p = 0.009). The prevalence of atrial fibrillation was also greater in the high-NETs group (65.9% vs 36.6%; p = 0.002). However, successful recanalization rates were similarly high in both groups (96.6% vs 97.6%; p = 0.99). Safety data regarding adverse events, serious adverse events, and discontinuations were not reported.

Key limitations include the retrospective nature of the study and its single-center setting at West China Hospital. The evidence establishes an association but does not establish causality. Practice relevance is currently limited by these observational constraints and the lack of reported safety data. Clinicians should consider these findings as hypothesis-generating rather than definitive for clinical decision-making.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
ObjectiveTo investigate the association between neutrophil extracellular traps (NETs) content in retrieved thrombi and 90-day functional outcomes in patients with acute ischemic stroke (AIS) secondary to anterior circulation large vessel occlusion (LVO) undergoing mechanical thrombectomy (MT).MethodsThis retrospective study analyzed data from a prospectively maintained cohort of 129 consecutive AIS patients who underwent MT at West China Hospital between January 2023 and October 2024. Retrieved thrombi were stained for citrullinated histone H3 (CitH3) and myeloperoxidase (MPO) using immunofluorescence, and the percentage of positive area was quantified to represent NETs content (% area). Patients were dichotomized into high-NETs and low-NETs groups based on an optimal cutoff determined by receiver operating characteristic (ROC) curve analysis for predicting poor outcome (modified Rankin Scale [mRS] score 3–6). The primary endpoint was functional independence (mRS 0–2) at 90 days. Multivariable logistic regression was employed to identify independent predictors of outcome.ResultsThe ROC analysis yielded an AUC of 0.644. The optimal cutoff value of defining high NETs content was 2.01%. Among 129 patients (mean age 67.9 years, 48.8% male), 88 (68.2%) were in the high-NETs group. Baseline characteristics were largely comparable, though the high-NETs group had significantly higher admission blood glucose (7.9 vs. 6.7 mmol/L, p = 0.009) and a greater prevalence of atrial fibrillation (65.9% vs. 36.6%, p = 0.002). Despite achieving similarly high rates of successful recanalization (mTICI 2b-3) in both groups (96.6% vs. 97.6%, p = 0.99), patients in the high-NETs group had a significantly lower rate of 90-day functional independence (35.2% vs. 68.3%, p 
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.